Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The Diabetes Market is driven by large diabetic patient pool caused by rapid urbanization and sedentary lifestyle. In addition, factors such as more R&D in diabetes diagnosis, technological advancements in the field of diabetes devices and a demand for faster and safer diagnosis & treatment of diabetes are adding to growth. The growing demand for minimally or non-invasive products is expected to propel the market growth further.
There are certain restraints in the market such as high cost associated with the diagnosis and treatment, irregular reimbursement and patent expiry. In addition, certain devices don't give an exact figure but a range in which a certain parameter may lie, for example, blood glucose monitoring devices give a range about the blood glucose level of a patient.
Market Segmentation
The market is segmented into
Glucose Monitoring Devices Market
--> Blood glucose meters
--> Testing strips
--> Blood glucose testing strips
--> Continuous glucose monitoring device
--> Lancets
Insulin Delivery Devices Market Glucose
--> Insulin syringes
--> Insulin pumps
--> Insulin pens
--> Insulin injectors
Geographic Analysis
North America has the largest market share of around 32% in 2015 and is expected to grow at a CAGR of 5.9%. The US is the major revenue pocket in this region. In 2015, Europe was the second largest market followed by Asia-Pacific. Asia-Pacific will be the fastest growing segment in this market especially countries like China and India owing to the high prevalence of diabetes, growing disposable income, rising awareness regarding these devices among others.
Key Companies
The key players profiled in this market are Abbott Laboratories, Dexcom Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Johnson & Johnson, Dexcom Inc., F. Hoffmann-La Roche Ltd, Medtronic plc and Terumo Corporation.
The report contains comprehensive analysis on:
--> Diabetes Devices Market Segments
--> Diabetes Devices Market Drivers, Restraints and Opportunities
--> Diabetes Devices Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Diabetes Devices Market Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis Diabetes Devices Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...